Global Atrial Fibrillation Market Analysis 2025–2029: Opportunities for Strategic Growth

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Atrial Fibrillation Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The atrial fibrillation market size has experienced rapid expansion in recent years. It is anticipated to increase from $13.56 billion in 2024 to $15.1 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.4%. The expansion observed historically is attributable to factors like heightened awareness and screening initiatives, innovations in treatment technology, greater healthcare spending, continuous clinical research and drug development, and genetic predispositions.

The atrial fibrillation market is anticipated to experience substantial growth in the upcoming years. It is projected to expand to $24.72 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 13.1%. This expansion during the forecast period can be attributed to a focus on stroke prevention, educational programs for patients and physicians, global cardiovascular health initiatives, an increase in electrophysiology procedures, personalized treatment plans, and government efforts for cardiovascular disease prevention. Significant trends expected during this period include advancements in diagnostic technologies, a rise in the incidence of atrial fibrillation, improvements in catheter ablation techniques, the emergence of novel oral anticoagulants (NOACs), the integration of wearable technologies for monitoring, the expanding role of telemedicine in AF management, and progress in implantable devices.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8007&type=smp

What Are The Main Drivers Boosting The Atrial Fibrillation Industry’s Expansion?

The increasing geriatric population is anticipated to propel the atrial fibrillation market forward. The geriatric population comprises adults 65 and older who are more susceptible to falls due to various factors like postural hypotension and issues with balance or gait. In most older patients, age-related factors and conduction disturbances are evident on a surface electrocardiogram prior to AF onset. For instance, in October 2022, the World Health Organization, a Switzerland-based specialized agency of the United Nations responsible for international public health, reported that by 2030, six people in the world will be aged 60 years or older. At that point, the number of individuals aged 60 or more will reach 1.4 billion, an increase from 1 billion in 2020. Globally, the count of individuals 60 and older is projected to double to 2.1 billion by 2050. Between 2020 and 2050, there will be an additional 426 million people aged 80 or older. Therefore, the expanding geriatric population is a key driver for the growth of the atrial fibrillation market.

How Is The Atrial Fibrillation Market Classified Into Different Segments?

The atrial fibrillationmarket covered in this report is segmented –

1) By Type: Surgical; Non-Surgical

2) By Technology: Radiofrequency; Laser; Cryotherapy; Other Technologies

3) By Treatment Type: Pharmacological Treatment; Non-pharmacological Treatment; Maze Surgery; Electric Cardioversion

4) By End User: Hospitals; Electrophysiology Labs; Ambulatory Surgical Centers

Subsegments:

1) By Surgical: Catheter Ablation; Maze Procedure; Hybrid Ablation Procedures

2) By Non-Surgical: Antiarrhythmic Drugs; Anticoagulants; Cardioversion Procedures; Device Implants

What Trends Are Expected To Drive The Atrial Fibrillation Market?

Leading companies in the atrial fibrillation market are introducing innovative products and solutions, such as patient-focused clinical decision support tools, to enhance their standing. Clinical decision support tools (CDSTs) are software or electronic systems developed to assist healthcare professionals in making informed and timely decisions regarding patient care. These tools aim to integrate relevant clinical information from diverse sources. For instance, in August 2023, GE HealthCare, a US-based multinational medical technology company, launched CardioVisio. This patient-centered clinical decision support tool is designed to help doctors make evidence-based clinical decisions guided by current atrial fibrillation guidelines and visualize longitudinal data from various sources relevant to illness progression. CardioVisio for atrial fibrillation specifically assists cardiologists in streamlining the interpretation of clinical images and provides a comprehensive view of the patient’s heart history and their overall healthcare journey, including previous diagnoses, prescribed medications, interventions, and comorbidities.

Who Are The Core Companies Influencing The Atrial Fibrillation Market Landscape?

Major companies operating in the atrial fibrillation market are AtriCure Inc., Johnson & Johnson Private Limited, Abbott Laboratories, C.H. Boehringer Sohn AG & Co. KG, Biotronik Se & Co. Kg, Boston Scientific Corporation, Bristol-Myers Squibb Company, CardioFocus Inc., Sanofi S.A, Medtronic PLC, Biosense Webster Inc., MicroPort Scientific Corporation, Siemens AG, Acutus Medical Inc., AEGEA Medical Inc., Apama Medical Inc., Aria CV Inc., Armetheon Inc., BioSig Technologies Inc., Cardialen Inc., CardioRobotics Inc., CardioInsight Technologies Inc., Circa Scientific LLC, CorWave SA, EpiEP Inc., Farapulse Inc., Fibralign Corporation, Impulse Dynamics NV, JenaValve Technology Inc., Kardium Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/atrial-fibrillation-global-market-report

Which Global Regions Are Influencing The Competitive Landscape Of The Atrial Fibrillation Market?

North America was the largest region in the atrial fibrillation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the atrial fibrillation market report forecast period. The regions covered in the atrial fibrillation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Atrial Fibrillation Market Report:

https://www.thebusinessresearchcompany.com/customise?id=8007&type=smp

Browse Through More Reports Similar to the Global Atrial Fibrillation Market 2025, By The Business Research Company

Arrhythmia Monitoring Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/arrhythmia-monitoring-devices-global-market-report

Cardiac Rhythm Management Crm Devices And Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-rhythm-management-crm-devices-and-equipment-global-market-report

Cardiac Pacemakers Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cardiac-pacemakers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795